Levodopa for the Treatment of Parkinson's DiseaseLEWITT, Peter A.The New England journal of medicine. 2008, Vol 359, Num 23, pp 2468-2476, issn 0028-4793, 9 p.Article

Sensory Trick in Hemichorea-Hemiballism and in Parkinson's Disease TremorLEWITT, Peter A; GOSTKOWSKI, Michal T.Movement disorders. 2010, Vol 25, Num 9, pp 1312-1313, issn 0885-3185, 2 p.Article

Clinical trials of neuroprotection for Parkinson's diseaseLEWITT, Peter A.Neurology. 2004, Vol 63, Num 7, pp S23-S31, issn 0028-3878, SUP2Article

New developments in levodopa therapyLEWITT, Peter A; NYHOLM, Dag.Neurology. 2004, Vol 62, Num 1, pp S9-S16, issn 0028-3878, SUP1Article

Subcutaneously administered apomorphine: Pharmacokinetics and metabolismLEWITT, Peter A.Neurology. 2004, Vol 62, Num 6, pp S8-S11, issn 0028-3878, SUP4Article

Standardized training tools for the UPDRS Activities of Daily Living scale: Newly available teaching programGOETZ, Christopher G; LEWITT, Peter A; WEIDENMAN, Meredith et al.Movement disorders. 2003, Vol 18, Num 12, pp 1455-1458, issn 0885-3185, 4 p.Article

Advanced Parkinson disease treated with rotigotine transdermal system PREFER StudyLEWITT, Peter A; LYONS, Kelly E; PAHWA, Rajesh et al.Neurology. 2007, Vol 68, Num 16, pp 1262-1267, issn 0028-3878, 6 p.Article

Early complement activation increases in the brain in some aged normal subjectsLOEFFLER, David A; CAMP, Dianne M; SCHONBERGER, Michael B et al.Neurobiology of aging. 2004, Vol 25, Num 8, pp 1001-1007, issn 0197-4580, 7 p.Article

Lack of evidence for Nocardia asteroides in brain specimens from lewy body-containing disordersLIN LU; CAMP, Dianne M; LOEFFLER, David A et al.Microbial pathogenesis. 2005, Vol 39, Num 5-6, pp 205-211, issn 0882-4010, 7 p.Article

Pharmacokinetic-Pharmacodynamic Crossover Comparison of Two Levodopa Extension StrategiesLEWITT, Peter A; JENNINGS, Danna; LYONS, Kelly E et al.Movement disorders. 2009, Vol 24, Num 9, pp 1319-1324, issn 0885-3185, 6 p.Article

Adenosine A_2A Receptor Antagonist Istradefylline (KW-6002) Reduces Off' Time in Parkinson's Disease : A Double-Blind, Randomized, Multicenter Clinical Trial (6002-US-005)LEWITT, Peter A; GUTTMAN, M; TETRUD, James W et al.Annals of neurology. 2008, Vol 63, Num 3, pp 295-302, issn 0364-5134, 8 p.Article

Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study)LEWITT, Peter A; HAUSER, Robert A; MEI LU et al.Neurology. 2012, Vol 79, Num 2, pp 163-169, issn 0028-3878, 7 p.Article

Nocardia asteroides culture filtrates cause dopamine depletion and cytotoxicity in PC12 cellsCAMP, Dianne M; LOEFFLER, David A; RAZOKY, Bnan A et al.Neurochemical research. 2003, Vol 28, Num 9, pp 1359-1367, issn 0364-3190, 9 p.Article

The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's diseaseHEIKKINEN, Helena; NUTT, John G; LEWITT, Peter A et al.Clinical neuropharmacology. 2001, Vol 24, Num 3, pp 150-157, issn 0362-5664Article

Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS) : Process, format, and clinimetric testing planGOETZ, Christopher G; FAHN, Stanley; HOLLOWAY, Robert et al.Movement disorders. 2007, Vol 22, Num 1, pp 41-47, issn 0885-3185, 7 p.Article

Characterization of dopamine-depleting activity of Nocardia asteroides strain GUH-2 culture filtrate on PC12 cellsLOEFFLER, David A; CAMP, Dianne M; QU, Shirley et al.Microbial pathogenesis. 2004, Vol 37, Num 2, pp 73-85, issn 0882-4010, 13 p.Article

Double-blind, randomized, controlled trial of Rasagiline as monotherapy in early Parkinson's Disease patientsSTERN, Matthew B; MAREK, Kenneth L; FRIEDMAN, Joseph et al.Movement disorders. 2004, Vol 19, Num 8, pp 916-923, issn 0885-3185, 8 p.Article

In situ hybridization for detection of nocardial 16S rRNA: reactivity within intracellular inclusions in experimentally infected cynomolgus monkeys-and in Lewy body-containing human brain specimensCHAPMAN, Gail; BEAMAN, Blaine L; LOEFFLER, David A et al.Experimental neurology (Print). 2003, Vol 184, Num 2, pp 715-725, issn 0014-4886, 11 p.Article

Transdermal dopaminergic D₂ receptor agonist therapy in Parkinson's disease with N-0923 TDS: A double-blind, placebo-controlled studyHUTTON, J. Thomas; VERHAGEN METMAN, Leo; WATERS, Cheryl H et al.Movement disorders. 2001, Vol 16, Num 3, pp 459-463, issn 0885-3185Article

A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for Parkinsonian off-state eventsDEWEY, Richard B; HUTTON, J. Thomas; LEWITT, Peter A et al.Archives of neurology (Chicago). 2001, Vol 58, Num 9, pp 1385-1392, issn 0003-9942Article

Urate as a Predictor of the Rate of Clinical Decline in Parkinson DiseaseASCHERIO, Alberto; LEWITT, Peter A; SCHWID, Steven R et al.Archives of neurology (Chicago). 2009, Vol 66, Num 12, pp 1460-1468, issn 0003-9942, 9 p.Article

Page / 1